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INTRODUCTION
Christianson syndrome (CS, OMIM 300243) is a rare, X-chromosome linked neurodevelopmental/neurological disorder characterized in males by nonverbal status, intellectual disability, epilepsy, craniofacial dysmorphology with microcephaly, truncal ataxia and hyperkinesis. These core phenotypic features (present in >85% of patients) may be accompanied by secondary symptoms such as signs of autism and behavioral abnormalities mimicking Angelman syndrome, eye movement problems, hypotonia or gastroesophageal reflux disease (for further information see Pescosolido et al., 2014) . MRI imaging studies have suggested hippocampal and/or progressive cerebellar atrophy in male CS patients (Gilfillan et al., 2008; Schroer et al., 2010; Mignot et al., 2013) . Furthermore, neuropathological reports in male CS brains demonstrated widespread neurodegeneration including loss of Purkinje cells, dystrophic neuritic changes, gliosis and tau deposition (Christianson et al., 1999; Garbern et al., 2010) .
CS develops as a result of mutations in the solute-carrier 9A6 gene (SLC9A6, Xq26.3) (Gilfillan et al., 2008) . SLC9A6 codes a multi-pass transmembrane protein (NHE6) that is believed to co-regulate luminal pH of early/recycling endosomes by its sodium (potassium)hydrogen antiporter activity (Ohgaki et al., 2011; Kondapalli et al., 2014) . A significant fraction of the reported SLC9A6 mutations are nonsense or shift the open reading frame of SLC9A6 and result in introduction of premature STOP codons (reviewed by Pescosolido et al., 2014) .
Due to X-chromosome inactivation (XCI), female heterozygotes presumably express SLC9A6 mutations in their cells/tissues mosaically. Despite several female heterozygotes presented with clinical symptoms reminiscent of those identified in their CS affected male relatives (Christianson et al., 1999; Gilfillan et al., 2008; Schroer et al., 2010; Pescosolido et al., 2014) conclusive information about the range of the likely mitigated and/or variable clinical phenotype in this particular group still remains to be systematically considered.
Previous studies by us and others demonstrated the relevance of the knockout of the murine Slc9a6 gene (Slc9a6KO) for studies exploring the human CS phenotype. Our analyses of mutant Slc9a6KO males (Slc9a6 -/Y /mut males) and homozygous mutant Slc9a6KO females (Slc9a6 -/-/mut females), both of which serve as models with uniform tissue distribution of the (transcriptionally) active mutant Slc9a6 allele, implied late endosomal-lysosomal dysfunction characterized by intraneuronal accumulation of GM2 ganglioside and unesterified cholesterol in the amygdala and the CA3/CA4 and fascia dentata regions of the hippocampus (Stromme et al., 2011) . In addition, both mut males and mut females expressed progressive, patterned Purkinje cells (PC) degeneration associated with axonal spheroid formation. Behavioral testing in mut males further revealed mild but significantly increased locomotor activity and motor coordination deficits suggesting further overlap with the human CS clinical condition (Pescosolido et al., 2014) . Importantly, a subsequent study which used in vitro experimental approaches in neuronal cultures derived from the Slc9a6KO model, proposed that abnormal endosomal acidification caused by the NHE6 deficit attenuates TrkB signaling and results in underdeveloped cortical and hippocampal neuritic arborization (Ouyang et al., 2013) .
Although different in specific molecular details from humans, the random XCI and its propagation in the tissues of the developing embryo are replicated in mice (Deng et al., 2014) . In the murine female brain, XCI topography generates intra-and inter-individual diversity that ranges from individual cells to the entire organ. Critical though, it was show that specific neuronal populations in female mice may tend, as a result of the complex neurodevelopment, to be non-randomly inactivated on a functionally relevant spatial scale (Wu et al., 2014) . Critical for our studies, the murine KO model carries an insertion of the LacZ-Neo cassette into the exon 6 of the Slc9a6 gene (X.A5) (Stromme et al., 2011) . LacZ that codes nuclear targeted -galactosidase (bGal) from E.coli thus serves both as a mutagen obliterating the Slc9a6 open reading frame but also as a transcriptional reporter allowing effective tracing of the cellular expression of the mutant Slc9a6 allele. Important for utility of the bGal reporter, its expression patterns correspond to the endogenous expression of the protein as identified by mRNA expression studies (Kondapalli et al., 2013) and/or specific anti-NHE6 antibody (Deane et al., 2013; Ouyang et al., 2013) . As a further important prerequisite, the murine Slc9a6 gene was not previously identified, similarly to humans (Cotton et al., 2015) , among X-linked genes that escape XCI (Yang et al., 2010) . Therefore critical for the presented study, bGal expression may also be considered to reflect the inactivation of the wt Slc9a6 allele in tissues of heterozygous Slc9a6KO female (Slc9a6 -/+ /het females) mice.
Given the relevance of the murine model for the CS and motivated to provide insights into the potential disease phenotype in human female heterozygotes carrying the SLC9A6 mutations, we performed a study to evaluate neuropathology and behavioral presentation in heterozygous Slc9a6KO female mice. Here we focused on delineating the mosaic patterns of abnormal intraneuronal lysosomal GM2 ganglioside accumulation in amygdala and hippocampus, characterizing the extent of cerebellar PC degeneration, and comparing the range of motor coordination and cognitive deficits to the abnormalities observed in mutant Slc9a6KO males.
RESULTS

Expression of the mutant Slc9a6 allele is mosaic in the brains of het female mice.
Cellular and tissue expression of the mutant Slc9a6 allele can be tracked by the LacZ encoded bGal reporter. Using the histochemical X-GAL based approach, we previously documented the brain specific expression patterns of bGal in mut males and mut females (Stromme et al., 2011) . Aware of the limitations of the histochemical technique and poised to qualitatively and quantitatively assess bGal expression in the brains of het females, we tested the utility of a specific antibody for detection of the reporter protein. To allow multiimmunofluorescence (IF) tissue labeling experiments, we selected a specific anti-E.coli bGal antibody raised in chicken.
To assess the progression of disease at later ages than previously reported (Stromme et al., 2011) and to fully document the reference neuropathology resulting from uniform tissue distribution of the (transcriptionally) active mutant Slc9a6 allele, we optimized IF staining conditions in the brains of X-chromosome hemizygous mut males (ages 4, 20-22 and 32-34 weeks). We compared the results with negative findings in age-matched wt males (shown in the cerebellar PC layer in supplementary material Fig. S1C ) and wt females (data not shown). The anti-bGal antibody generated a nuclear staining pattern in the brains of mut males allowing us to confirm that the expression patterns of bGal by IF corresponded to those previously identified by X-GAL histochemistry (Stromme et al., 2011; Ouyang et al., 2013) .
In agreement also with studies by others (Deane et al., 2013; Kondapalli et al., 2013; Ouyang et al., 2013) , the versatility of the multi-IF technique allowed us to further demonstrate that bGal expression was not limited exclusively to nuclei of neurons, but could be identified also in GFAP+ astrocytes and APC2+ oligodendroglial cells ( Fig. 1A and 1C ) in the cerebra of the mut males. As a result of the small nuclear size and relatively high levels of the endogenous cytoplasmic autofluorescence, we were not able to unambiguously identify bGal expression in CD68+ microglia/macrophages (data not shown). Critical for progression of the neuropathological changes in mut males, we also specifically assessed bGal in the cerebella and confirmed a strong expression in nuclei contained within the Purkinje cell (PC) layer. Despite slight variability, bGal expression was uniform in PCs. Expression was also strong in the GFAP+ astrocytes (Bergmann glia) adjacent to PCs (supplementary material Fig.  S1A and Fig. 4A ).
At the level of individual cells and regardless of a particular cell type, nuclear bGal expression was either comparable to the levels observed in mut males or was altogether absent in Slc9a6 het females ( Fig. 1B, 1D , 4B and 4C, and supplementary material Fig. S1B ). While the overall mosaic patterning was variable between individual het female brains, it did not have a tendency to focal clustering of cells with either of the two disparate expression bGal profiles. Important, the mosaic bGal expression was detected in neuroanatomic locations previously identified as critical (brain cortex, hippocampus, amygdala and cerebellar PC layer) for initiation and progression of the abnormal phenotype in mut males.
Intracellular accumulation of GM2 ganglioside is mosaic in het females and develops in cells expressing the mutant Slc9a6 allele.
The vacuolar intracellular GM2 ganglioside accumulation previously identified in specific neuronal populations in cerebra of mut males and mut females was believed to reflect late endosomal-lysosomal dysfunction. This particular subcellular pathology develops in CA3/CA4 regions of hippocampus and amygdala of these animals as early as at 3 weeks of age (Stromme et al., 2011) . Utilizing the IF-based bGal detection, we evaluated the presence of the abnormal GM2 accumulation and correlated it with the mosaic expression of bGal in the brains of het females. Moreover, we assessed the timing and progression of GM2 accumulation by analyzing both animals aged 4 weeks as well significantly older (32-34 weeks) mut males and het females.
Serving as a reference phenotype, mut males showed GM2 accumulation in neurons of hippocampal CA3/CA4 regions and amygdala at 4 weeks of age ( Fig. 2A ). In neurons of the CA3/CA4 region of hippocampus, the nuclear bGal expression and GM2 ( Fig. 2E ) accumulation were uniform with both signals co-occurring in individual cells. On the contrary, the number of bGal+ cells/neurons in amygdala was larger than the number of cells accumulating GM2. Nevertheless, nuclei of the GM2 accumulating neurons ( Fig. 2C ) consistently stained with anti-bGal antibody. To explore this numeric difference, we searched the amygdala of mut males using electron microscopy to identify the abnormal glycolipid containing concentric lamellar bodies. In agreement with the multi-IF staining, we found that a number of neurons lacked the specific lysosomal storage structures ( Fig. 2C ). Altogether, these observations suggest that in mut males only a subpopulation of neurons (supplementary material Fig. S2 ) in amygdala abnormally accumulates GM2 (and likely also other glycolipids) despite expressing the mutant Slc9a6 allele from their single X-chromosome.
We further assessed the age related persistence of GM2 accumulation by co-staining cerebra of significantly older mut males (32-34 weeks). In these, we found that the patterns of bGal expression and the abnormal GM2 accumulation ( Fig. 2G ) corresponded to those identified in 4 week-old brains.
In het females ( Fig. 2B, 2D , 2F, and 2H), the neuronal GM2 pathology as well as its timing corresponded to the findings in mut males. Critically, the occurrence of GM2 accumulation was, in individual neurons, linked to mosaic nuclear expression of the bGal reporter. The correlation of the mosaic bGal expression and GM2 accumulation could be easily discerned in the hippocampal CA3/CA4 region ( Fig. 2F and 2H ). In amygdala, bGal expression was also mosaic (Fig. 1B, 2D ). Identical to mut males ( Fig. 2C ), nuclei of neurons accumulating GM2 in amygdala were also bGal+ in het females, nonetheless, some of the bGal+ cells did not accumulate GM2 ( Fig. 2D ).
As controls, age/sex-matched wt littermate brains were negative for bGal expression and did not show intraneuronal GM2 accumulation. To further check for possible neurodegeneration in the regions affected by the glycolipid accumulation in mut males and het females, we IF co-stained cerebra of animals of both these genotypes with antibodies targeting neurons (anti-NeuN) and microglia/macrophages (anti-CD68). In contrast to the cerebellum (see below) and when compared to wt controls, none of these stains directly or indirectly suggested widespread neurodegeneration at 4 and/or 32-34 weeks of age (data not shown).
Purkinje cells in Slc9a6KO het females exhibit degeneration that is ameliorated compared to mut males.
Degeneration of PCs that associates with spheroid formation on their axons is another feature consistently discernible in mut males. The spatial patterning of this process follows cerebellar zonal organization with Zebrin II positive PCs being the most resistant to decay (Stromme et al., 2011) . Transformed to (para)sagittal projection (Sillitoe and Joyner, 2007) , PCs in the anterior (lobules I-V) and posterior (lobule VIII) cerebellar zones tend to degenerate earlier than those localized to the central (lobule VI/VII) and nodular zones (lobules IX/X). The molecular and developmental basis of this pattern remains to be fully understood, nonetheless, as observed in mut males it is replicated in other murine disease models that develop PC degeneration (e.g. Niemann-Pick diseases types A/B or C, (Sarna et al., 2001; Macauley et al., 2008) ).
We evaluated cerebellar pathology both in 4 week and 32-34 week-old animals. Neurono/dendritophagic clustering of CD68+ macrophages/microglia in the PC and molecular layers of cerebellar lobules I-II, III, and VIII ( Fig. 3A and 3C) suggested ongoing PC loss (visualized by calbindin IF staining) in these areas already in 4 week-old mut males. Identical but less profound changes than those identified in mut males were detected also in 4 week-old het females ( Fig 3B and 3D) .
At 32 weeks, cerebella of mut males showed extensive PC loss in anterior and posterior zones ( Fig. 3E ). This pathology was further associated with atrophy and gliosis of the cerebellar molecular layer in these zones (shown for lobule I-II in the supplementary material Fig. S1A ). CD68+ cells were frequent in these cerebellar cortical areas, nonetheless, they did not form PC neuronophagic clusters comparable to 4 week-old animals (data not shown). To document the major quantitative difference in a cohort of 32 week-old mut males, we sampled the density of PCs in lobule I-II and lobule X selected as representative of zones affected and spared from PC degeneration, respectively. The density of PCs in lobule I-II was significantly lower in mut compared to wt males (F(1, 7)=227.4, p<0.0001, Fig. 3G ).
Critical for 32 week-old het females, the extent of PC degeneration was not histologically as discernible ( Fig. 3F ) as in mut males. The secondary gliosis in the molecular layer of lobules affected by PC degeneration was also less profound in het females (supplementary material Fig. S1B ) than in mut males. Despite these mitigated histological findings, the density of PCs in lobule I-II in het compared to wt females was significantly lower (F(1, 21)=24.9, p<0.0001, Fig. 3H ).
While bGal expression could be considered uniform in mut males ( Fig. 4A and supplementary material Fig. S1A ), in het females at 32 weeks of age, bGal expression was mosaic in the PC layer and was also confined both to PCs as well as to nuclei of GFAP+ astrocytes (Bergmann glia, supplementary material Fig. S1B ). Unlike mut males, however, PC densities and the numbers of (bGal+) PCs varied between individual het female cerebella (compared in two selected animals in Fig. 4B and 4C ). To reiterate, and contrary to lobule X, the overall density of PCs was significantly lower in lobule I-II of het females when compared to their wt littermates ( Fig. 3H ). To quantitate the likely selection against (bGal)+ PCs, we compared the fractional (%) content of (bGal+) PCs in lobules I-II (mean value was 12.8) and X (mean value was 32.4%) among het females and found that this fraction was significantly lower in lobule I-II (F(1, 29)=44.6, p<0.0001, Fig. 4D ).
As a last, but important detail, spheroid formation affected axons of (bGal+) PCs both in mut males (Fig. 4A ) as well as het females (Fig. 4C ).
Slc9a6KO het females have cognitive deficits and sensorimotor dysfunction.
In behavioral tests we found that het females generally demonstrated similar motor incoordination and cognitive deficits as did male mutants, albeit some of the phenotypes were less profound in these mice. Mutant males (32-34 week-old) had significantly higher locomotor activity in the open field (total track length, F(1, 59)=5.7, p<0.05; Fig. 5A ) and exploration (number of rears, F(1, 59)=12.5, p<0.05; Fig. 5B ) than wt males. Similar to the previous study in younger (20) (21) (22) (23) (24) week-old) animals (Stromme et al., 2011) , we identified no differences in the anxiety-like behavior (ratio of track length in center zone to total track length, Fig. 5C ). Unlike the males, het and wt females at the age of 32-34 weeks did not differ in track length, rears or anxiety-like behavior ( Fig. 5D-5F ).
Consistent with the substantial cerebellar pathology, mut males also had significant motor coordination deficits assessed as increased number of slips in the balance beam assay (F(genotype 1, 84)=32.9, p<0.0001 and F(age 1, 86)=11.9, p<0.001; Fig. 5G ). Similar to the previous study (Stromme et al., 2011) , gross ataxia and motor incoordination were not detectable at 20-22 weeks in mut males but could be readily identified in animals aged 32-34 weeks. Given the mitigated cerebellar neuropathology, female heterozygotes also had significant motor coordination deficits in the balance beam compared to age matched wt controls (F(genotype 1, 105)=5.3, p<0.05 and F(age 1, 105)=8.4, p<0.01; Fig. 5G ). Importantly, none of the evaluated het females presented with obvious ataxia even at 32-34 weeks of age.
Given the hippocampal neuropathology of both mut males (Stromme et al., 2011; Ouyang et al., 2013) and het females (shown in this study), we evaluated visuospatial memory in the hippocampus-dependent object placement test (Ennaceur and Delacour, 1988; Dere et al., 2007) and found deficits in both mut males and het females at 20-22 weeks of age ( Fig.  5H ). Mut males (T(df=23)= 1.15, p<0.26) and het females (T(df=24)= 0.33, p<0.75) failed to display the preference for a re-located object (new position not significantly greater than old position). In contrast, their age-matched wt littermates (wt males: T(df=14)= 5.3, p<0.0001; wt females: T(df=16)= 2.3, p<0.05) displayed the normal preference for a re-located object (new position significantly greater than old position). The preference for the re-located object (new position) in the testing phase was not confounded in animals of either sex by any non-specific alteration in the reactivity to novelty as assessed by the total exploration time in the training phase when no memory is involved (data provided in the supplementary material Fig. S3 ).
DISCUSSION
Our study demonstrates that expression of the mutant Slc9a6 allele in het female mice mosaically follows the neuroanatomic distribution and cell-type specific patterns identified in the brains of X-chromosome hemizygous mut males. As a consequence, het females develop behavioral and neuropathological abnormalities that are, albeit milder, comparable to defects identified in mut males. As a follow-up to our previous studies, by analyzing up to 8 monthold animals we document that specifically the sensorimotor dysfunction and the cerebellar PC degenerative pathology are progressive with age both in mut males and het females.
Overall, we propose that Slc9a6KO heterozygous female mice represent a relevant and critical model for future studies aimed at understanding the pathogenesis of human Christianson syndrome (CS). As the second pathology-expressing genotype relevant to human X-linked CS, het female mice should complement the experimental use of mut males. Due to the mosaic expression of the mutant Slc9a6 allele, we expect het females to become particularly useful for testing cell-autonomous nature of specific (neuro)pathologies and/or exploring the roles of intercellular interactions (neuronal circuitry dysfunction included) in the onset and progression of the abnormal phenotype. Similarly important will be studies aimed at exploring the embryonic/developmental impacts of XCI on the overall as well as site-specific brain (dys)function in het female mice.
The bacterial -galactosidase that reports the expression of the mutant Slc9a6 allele can be identified in murine tissues by a specific antibody. With IF, we confirmed cerebral and cerebellar bGal expression in large populations of neurons and astrocytes (Stromme et al., 2011; Deane et al., 2013; Kondapalli et al., 2013; Ouyang et al., 2013) in mut males and identified the mosaic bGal presence in these cell types/locations in het females. Knowing the expression patterns in mut males, presuming that the murine Slc9a6 gene does not escape XCI (Yang et al., 2010) and comparing our results to the recently published XCI topography maps of the female murine brain (Wu et al., 2014) , we explain the mosaic bGal expression patterns in the brains of het female mice by X-chromosomal inactivation (XCI). Previously unreported, we found bGal in APC2+ oligodendrocytes of both mut males and het females. In fact, this suggests further glial cell type theoretically compromised by the SLC9A6 deficit both in the mouse model as well as in CS patients.
Although the neuropathological findings in human hippocampi are relatively mild (Garbern et al., 2010) and hippocampal atrophy was identified by neuroimaging studies only in some male patients (Schroer et al., 2010) , dysfunction of hippocampus and amygdala can be presumed based on the clinical CS phenotype (Stromme et al., 2011) . Lysosomal accumulation of GM2 in neurons of hippocampal CA3/CA4 regions and basolateral amygdala is one of the early occurring abnormalities in Slc9a6 mut male mice. In the current study, we found that only a subpopulation of neurons in amygdala accumulates GM2. Molecular, structural and most importantly functional/connectivity characteristics (Capogna, 2014; Janak and Tye, 2015) of these neurons, determinants of their sphingolipid pathology and its contribution to the overall phenotype remains to be established. Critical though, in het female mice, the timing, neuroanatomic distribution and ultrastructural appearance of GM2 pathology are replicated. As an anticipated effect, GM2 accumulation in neurons of both hippocampus and amygdala correlated with the mosaically expressed mutant Slc9a6 allele in het females.
The early-onset degeneration of PCs and ataxia present in older mut male mice correspond to the clinical, neuroimaging and cerebellar pathology in male CS patients (Christianson et al., 1999; Gilfillan et al., 2008; Garbern et al., 2010; Schroer et al., 2010; Mignot et al., 2013) . More specifically, PC loss and consequent atrophic changes in the cerebellar cortex of mut males follow a previously described and conserved cerebellar developmental/gene-expression pattern (Stromme et al., 2011) . In het female mice, the mosaic bGal expression profiles in the cerebellar cortex correspond at the cellular level to the uniform expression found in mut males. PC degeneration in het females is initiated at the same age as in mut males and a selection against (bGal+) PCs is likely in het females in cerebellar cortical zones that are affected by degeneration in mut males. Importantly, the mean values (as well as their distribution among het females) of % fraction of bGal+ PCs in the cerebellar zone(s) not affected by degeneration even in older (32-34 weeks) mice suggest random XCI in this particular neuronal population. This result shows that direct detection of the bGal reporter in the brains of het females allows Slc9a6 allelic expression quantification even in numerically limited or anatomically restricted specific cellular types/populations. Besides neurons, we further found that GFAP+ cells (Bergmann glia) in the cerebellar cortex also express bGal. Aware of the intimate developmental, structural and functional association between PCs and Bergmann glia (Bellamy, 2006; Wang et al., 2012) that encompasses regulation of synaptic transmission and/or plasticity as well as buffering of extracellular K + and neurotrophin levels by astrocytes (Kondapalli et al., 2014) , we hypothesize that the PC degeneration in mut male or het female mice may not be an exclusively cell-autonomous event. If valid, the variable extent of XCI in PCs and cerebellar cortical astrocytes would likely, in conjunction with the microdomain and overall zonal organization of cerebellar cortex, represent a critical determinant of the cerebellar degenerative pathology in het females.
Critical for human CS, dominance and recessivity allelic relations valid for autosomal genes do not apply to X-chromosome linked traits (Dobyns et al., 2004) . While X-linked phenotypes are penetrant in X-chromosome hemizygous male patients, the clinical presentation in heterozygote female patients/carriers is mitigated and often variable. One of the principal underlying mechanisms for such variability in females is XCI in their tissues (Yang et al., 2011; Deng et al., 2014) . Unlike in males, data on the frequency of the mutations in X-linked genes associated with ID among females is largely unavailable as a likely result of the diversity of their clinical phenotype(s). Interestingly, it was shown that female heterozygotes in families with X-linked ID have significantly skewed XCI ratios in peripheral white blood cells (Plenge et al., 2002) . However, the relation of the skewed XCI status in leukocytes to the range and severity of the neurodevelopmental/neurological/psychiatric disease(s) still remains to be fully understood (Tzschach et al., 2015) . Consistent with cellular abnormalities, Slc9a6 het female mice showed the same cognitive and sensorimotor abnormalities, albeit mitigated, that were compromised in mut males. It remains for future studies, however, to attempt to establish neuroanatomic XCI thresholds for the behavioral pathologies and determine the sources of inter-individual variability in het female mice. Pescosolido et al. (2014) defined the core and secondary clinical features of CS by evaluating the largest cohort of affected families and male patients. Although reported inconsistently, a variable and mitigated phenotype seems likely also in female heterozygotes for SLC9A6 mutations. Here, some females have presented with neurodevelopmental delays, problems with speech, learning and/or behavioral difficulties, aggressiveness in childhood and adolescence, hyperkinesis or truncal ataxia (Christianson et al., 1999; Gilfillan et al., 2008; Schroer et al., 2010; Pescosolido et al., 2014) . Intriguingly for interpretation of these observations, Gilfillan et al (2008) partially excluded XCI as a contributor to the clinical CS presentation because several female heterozygotes in their pedigrees presented with normal XCI ratios in lymphocytes.
Several recent genomic projects (Tarpey et al., 2009; Schuurs-Hoeijmakers et al., 2013; Tzschach et al., 2015) demonstrated that CS is one of the most frequent X-linked neurodevelopmental ID disorders. However, the patient cohorts in these studies either consisted exclusively of male ID patients, their female relatives or included females with penetrant ID phenotypes. As a possible result of disqualifying individuals with mitigated or variable abnormalities (applicable specifically to female heterozygotes), the CS population frequency that was estimated based on some of these datasets as 1 in 16,000-100,000 (Pescosolido et al., 2014) could, in fact, be higher. Also relevant to the occurrence of CS, a substantial fraction of male CS probands develop the SLC9A6 mutations de-novo (Schroer et al., 2010; Pescosolido et al., 2014) . This lack of maternal inheritance in CS pedigrees has not yet been specifically explored for post-zygotic mutagenic events or low-level maternal somatic/germinal mosaicism, both of which result in variable non-homogeneous tissue distribution of SLC9A6 mutations. Because these phenomena are relatively frequent in the general population (Acuna-Hidalgo et al., 2015) they could theoretically represent an additional and disparate source of phenotypic variability contributing to the likely underdiagnosis of CS.
Here we have provided evidence for a behavioral and neuropathological phenotype in Slc9a6KO heterozygous female mice. Such findings, we believe, indicate a critical need to gain detailed insight into the range of potential phenotypes in heterozygous female CS patients/carriers. While we acknowledge that the homogenous genetic background of murine Slc9a6KO model may not necessarily reflect the complex and heterogeneous human genomics and X-linked epigenetics, we hypothesize that the expected XCI-driven expression (Cotton et al., 2015) of SLC9A6 mutations in the brains of human female heterozygotes contributes to the diversity of their resultant clinical presentation. Defining the full phenotypic spectrum in this potentially underappreciated patient group is, to us, a key prerequisite to delineate the population frequency of CS, avoid diagnostic neglect, and allow efficient genetic counseling and screening in affected families. Moreover, an evidence-based recognition of female CS heterozygotes as at risk or affected by a variable/mitigated disease could be an additional strong argument advocating for further experimental and clinical research including therapy development for this disorder.
MATERIALS AND METHODS
Mice and tissue collection
All procedures used in experiments involving animals were approved by the Institutional Animal Care and Use Committee of the Albert Einstein College of Medicine. The study used B6.129P2-Slc9a6 tm1Dgen/J (Slc9a6KO) mice originally acquired from the Jackson Laboratory (Bar Harbor, ME, USA). Genotyping of litters was performed as previously reported (Stromme et al, 2011) . In this study we utilized Slc9a6 wild-type male (Slc9a6 +/Y /wt males) and female (Slc9a6 +/+ /wt females) mice, X-chromosome hemizygous (mutant) Slc9a6KO male mice (Slc9a6 -/Y /mut males) and X-chromosome heterozygous Slc9a6KO females (Slc9a6 -/+ /het females). Homozygous (mutant) Slc9a6KO females (Slc9a6 -/-/mut females) were not tested. If not stated otherwise, results were compared between genotypes and separately for sexes of the animals (mut males wt males and het females  wt females). For tissue collection, mice were deeply anesthetized with ketamine-xylazine and perfused transcardially with saline and consequently with 4% paraformaldehyde (PFA). Dissected organs were further immersion fixed overnight in 4% PFA and then transferred to ice cold phosphate buffer and stored at 4°C. This study did not use any data/material generated in our previous study (Stromme et al., 2011) . Behavioral and tissue studies were performed in parallel and under identical conditions in all sex/genotype groups.
Antibodies and immunofluorescence
For immunofluorescence (IF) labeling, brains were divided along the midline and then split into cerebral and cerebellar/brain stem parts at the mesencephalic level. The separated fragments were embedded into 8.0% sucrose/3.5% agarose and 35 m thick serial sections (coronal in cerebrum and sagittal in cerebellum) were cut using Leica VT-1000S Vibratome (Leica Microsystems, Wetzlar, Germany). Sections representing rostral<>caudal bregma (-1.94<>-2.30) and lateral (0.40<>0.84) ranges (Franklin and Paxinos, 2008) were selected from cerebra and cerebella, respectively. Matched sections were stained by multi-IF protocols as described before (McGlynn et al., 2004) . The following primary antibodies were used for staining of specific epitopes: chicken anti-E.coli -galactosidase (bGal) Ab (1:2000, Abcam, Cambridge, MA, USA), mouse anti-calbindin (Purkinje cells) mAb D-28K (1:2000, Sigma-Aldrich, St. Louis, MO, USA), rabbit anti-calbindin pAb (1:800, Chemicon, Temecula, CA, USA), rat anti-CD68 mAb (1:1000, AbD Serotec, Kidlington, United Kingdom), mouse antiglial fibrillary acidic protein (GFAP) mAb G-A-5 (1:3000, Sigma-Aldrich), mouse antineurofilament (anti-NF) medium chain mAb (1:500, Novus Biologicals, Littleton, CO, USA), mouse anti-APC2 (oligodendroglial cells) (1:100, Calbiochem, San Diego, CA, USA), mouse anti-NeuN (neuronal nuclei) IgG mAb (1:1000, Chemicon), mouse anti-GM2 ganglioside IgM mAb (1:15, cell culture supernatant was produced in-house from the 10-11 hybridoma line by Progenics Pharmaceuticals, Tarrytown, NY, USA). Species specific secondary antibodies conjugated to Alexa Fluor (AF) 488, 546 and 633 (Invitrogen, Carlsbad, CA, USA) dyes were used for detection of primary antibodies. Minimum of 3 animals were evaluated for all sex/genotype groups aged 4 and 32-34 weeks. The number of cerebella analyzed in the quantitative studies in 32 week-old animals is listed in Legends to Figures 3, 4 and FigS1.
Light microscopy
Overview images (Fig. 1A, 1B, 2A, 2B, 3A, 3B, 3E and 3F) of the cerebral and cerebellar IF labeled sections were acquired using IX70 microscope (Olympus, Tokyo, Japan) equipped with HQ2 camera (Photometrics, Britannia, AZ, USA), Proscan II encoded xyz stage (Prior Scientific, Rockland, MA, USA) equipped with 10 position excitation/emission SmartShutters filter wheels (Sutter, Novato, CA, USA). Exposure time for all antibody combinations was 750 ms (gain 2 per channel. Excitation/emission conditions for the AF488 and AF546 dyes were exc.490/20/b.s. 480-513/em.535/40 and exc.572/23/b.s.555-588/em.630/60 nm, respectively. Individual but partially overlapping double channeled 14-bit images (down-sampled to 8-bit) were acquired with Plan 10x (NA 0.25) objective and were digitally stitched in Metamorph/MetaFluor (Molecular Devices, Sunnyvale, CA, USA) and consequently in Photoshop CS6 (Adobe, San Jose, CA, USA) software. Selected areas of the IF labeled sections (Figs. 1-4 and supplementary material Fig. S1 ) were imaged by laser scanning confocal microscope (Zeiss Meta Duo V2, Oberkochen, Germany) using Plan Apochromat 20 (NA 0.8) objective. Conditions of image acquisition (pinhole size, excitation laser intensity, scanning speed, dichroic mirrors, excitation/emission (band)-pass filters and photomultiplier gains) were kept constant for individual combinations of primary and secondary antibodies. Excitation/emission filtering was set to minimize cross talk and individual dyes were excited and their emission was collected sequentially. The final Z-stacks (thickness is reported in the Legends of the individual Figures) were transformed into single plain maximum intensity projection (MIP) images using the Zeiss LSM Image Browser (Zeiss). Images of amygdala and CA3 brain regions (Fig. 2C-H) represent scans with opened confocal pinhole allowing collection of the fluorescence information from the entire thickness of the section (35 m).
Electron microscopy
For electron microscopy, cerebra of 4-5 week-old wt and mut males and het females were coronally sectioned (250 m) using Vibratome. Sections containing hippocampal CA3 and amygdala regions were selected and these regions were manually dissected. The tissue blocks were first transferred to 0.1M cacodylate buffer and post-fixed in 2% glutaraldehyde. Samples were further washed and post-fixed in osmium (1% osmium in 0.1% cacodylate buffer), dehydrated and embedded in Epon-araldite. Ultrathin sections were stained with uranyl acetate and lead citrate, and examined with a Philips CM10 electron microscope (Philips Electron Optics, Eindhoven, The Netherlands).
Purkinje cell density counts
Serial cerebellar sagittal sections (35m thick) were visually searched for the first occurrence of the deep cerebellar nuclei (~0.48mm lateral (Figure 105 ) in Franklin and Paxinos (2008) ). Such a section was considered as section +1. This and three consecutive sections in lateral sequence (+3, +5 and +7) were stained with a combination of anti-calbindin (PC marker) and anti-bGal antibodies and secondary antibodies conjugated to AF488 and AF546, respectively (protocol modified for IF from (Praggastis et al., 2015) )). The total number of Purkinje cells (PC#), the number of PCs with bGal positive nuclei ((bGal+) PCs)) and the overall lengths of PC layers (in mm) were manually counted/traced in at least three out of the four selected sections in lobules I-II and X. The number of 32 week-old animals analyzed is provided in Legends to Figures 3, 4 , and S1. Stereo Investigator software (MBF Bioscience, Williston, VT, USA) installed to Olympus Bx51 microscope was used for outlining the PC layers and counting PCs. PC# and (bGal+) PC# were assessed using PlanFL 20x (N.A. 0.5) objective. While nuclei were co-detected by DAPI in all the double IF stained sections, the parallel triple fluorescent quantitation proved technically difficult due to unbalanced intensities and fluorescence bleaching of the three dyes. The total number of PCs with structurally identifiable nuclei in lobules I-II and X was first assessed using the fluorescence filter set discerning AF488 (exc.480/40/b.s.510LP/em.505LP). (bGal+) PCs were consequently quantified by changing the excitation/emission to a triple exc./em. (DAPI/FITC/TRITC) filter cube (Chroma set #61000v2, Bellows Falls, VT, USA). The overall PC density (PC#/1 mm of the length of the PC layer) and % fractions of (bGal+) PCs in individual animals were calculated in lobules I-II and X from values in the 35 m sections.
Behavioral studies
The strategy for behavioral testing was designed according to our previous analyses performed in mut and wt males aged ~20-24 weeks (Stromme et al., 2011) . Expecting a mitigated, delayed and also variable phenotype in het females compared to the reference abnormality in X-chromosome hemizygous mut males, we decided to substantially increase the number of tested animals in all compared sex/genotype groups and also perform some of the behavioral tests at an older age (weeks 32-34). Animals were tested for their voluntary locomotor and exploratory activities and anxiety-like (exploration of the center zone) behavior in an open-field. Motor coordination was assessed by the balance beam test. Spatial memory of the animals was tested in the object placement test. The timeline of the tests and ages of animals when tested were: balance beam at 20-22 and repeated at 32-34 weeks, object placement at 20-22 weeks, and open field at 32-34. Motor coordination was evaluated by counting the number of slips made while crossing a round 16 mm balance beam (120 cm long) (Stanley et al., 2005) . Prior to each testing session, mice were pre-trained to walk over a 6 cm wide flat wooden plank to diminish anxiety. Due to the time scale of the study (8 months) and tissue collection, some subjects were tested only once (either when 20-22 or 32-34 week-old) while majority was tested longitudinally. Locomotor activity, exploration and thigmotaxis (anxiety-like behavior) of the animals were assayed in the open field arena (37 x 42 cm) for 6 minutes. The total track length traveled in the entire arena was used as a measure of locomotor activity. Anxiety-like behavior was assessed as the proportion of the center zone (15 x 15 cm) exploration (center zone track) from the total track traveled. Both measures were assessed automatically using Viewer software (Biobserve, Bonn, Germany). Rears (exploration) were counted manually. For the object placement test (Ennaceur and Delacour, 1988; Dere et al., 2007) , animals were first allowed to explore a pair of identical, non-toxic objects for 5 minutes (training phase) in an open field with high contrast visual cues placed on each wall of the arena. Animals were then placed back into their home cages for 16 minutes (retention interval). Subsequently, one of the objects was moved to a new position while the position of the other object remained unchanged (old position) and the animals were allowed to explore both objects for 3 minutes (testing phase). Exploration of the objects was defined as any physical contact with an object (whisking, sniffing, rearing on or touching the object) or orienting to the object from within 5 cm. Viewing software (Biobserve) was used to record the sessions. Care was taken to ensure that intrinsic relationship between the objects as well as the relative position of the objects to the visual cues was altered. Total times (in seconds) spent exploring the objects in the old and new positions during the testing phase were compared. Animals with cumulative exploration times below 2 seconds in either training or testing phases were excluded from further analyses.
Statistical analyses and Figure preparation
JMP statistical software (v.11, SAS, Cary, NC, USA) was used to analyze the results of the behavioral and PC quantitation analyses. The balance beam data were analyzed by a mixedeffects analysis including random and fixed factors, similar to a standard repeated measures analysis, but with the advantage that missing data can be accommodated in a mixed effects model that thus analyzed both between (fixed) and within (random)-subjects variability while preserving the correct sample sizes and degrees of freedom (df) when some subjects were tested twice (Fig. 5G) . The results of the object placement test require analysis of time exploring the object in both new and old position for each subject (measured during the testing phase). Thus, to preserve the sample size and because the values represent 2 data points from each individual subject, these data were matched and analyzed by paired t-tests in each sex/genotype group. The rest of the statistical analyses (total track lengths, ratios of center and total track lengths, number of rears, total exploration time in the training phase of the object placement test, PC densities and comparisons of fractions of (bGal+) PCs in lobules I-II and X) were evaluated by one-way ANOVA test. p-values <0.05 were considered as statistically significant. Data in Figures 3, 4 (shown also as individual values) and 5, in the text and supplementary material are presented as arithmetic mean values  standard errors of mean. Figures were prepared in Photoshop CS6 (Adobe, San Jose, CA, USA) and graphs were plotted in GraphPad Prism version 6.05 software (GraphPad software, La Jolla, CA, USA). For better contrast and visibility and not to alter the biological information, images were stretched to fill the full dynamic 8 bit-ranges. Nuclear expression patterns of the bGal reporter in the brain of X-chromosome hemizygous mut male (A) are mosaically replicated in het female (B). Opposed to mut males (C), het females express bGal mosaically in neurons (NeuN+), astrocytes (GFAP+) and oligondrendroglial cells (APC2+) (D). Arrowheads depict bGal negative astrocytes and oligodendroglial cells. The abnormal intraneuronal accumulation of GM2 ganglioside in amygdala and CA3 region of hippocampus is found in the neurons expressing the mutant (bGal+) Slc9a6 allele in het females.
At 4 weeks of age, GM2 accumulation is conspicuously present in the neurons of CA3 region of hippocampus (white arrowheads) and amygdala (blue arrowheads) of mut males (A) as well as in het females (B). In mut males, only a fraction of bGal+ neurons in amygdala accumulates GM2. The intracellular glycolipid accumulation adopts the form of concentric lamellar bodies by electron microscopy (C, and supplementary material Fig. S2 ). In het females, bGal+ and bGal+/GM2+ neurons are less frequent than in mut males. The lysosomal ultrastructural abnormalities found in het females (D) are equivalent to findings in mut males. Whereas CA3 neurons in mut males express bGal and accumulate GM2 uniformly (E and G), GM2 accumulation in CA3 neurons of het females is mosaic and reflects the expression of the mutant (bGal+) Slc9a6 allele (F and H). 
Cerebellar pathology in het females.
Degeneration of Purkinje cells (visualized by calbindin IF staining) in anterior and posterior zones is initiated in mut males (A) as well as het females (B) as early as at 4 weeks of age and is highlighted by the abnormal population of CD68+ microglia in both genotypes (arrowheads). Neuronophagy of PC cell bodies (arrowheads) and dendrites in the molecular cerebellar layer can be readily identified at this age by confocal microscopy in both sex/genotype groups by clusters of CD68+ microglia/macrophages (C and D). At 32 weeks of age, mut males (E) present with advanced and wide-spread loss of Purkinje cells in anterior (lobule I-V) and posterior (lobule VIII) cerebellar zones (arrowheads). In het females, PC degenerative patterns (F) are not as evident as in mut males and vary among individual animals. PC density quantitation (G, H) in lobules I-II (representative of the anterior zone) and X (representative of the nodular zone) showed significant PC loss in lobule I-II of 32 week-old mut males and het females (n=4 wt and 5 mut males and 6 wt and 17 het females) in contrast to lobule X (n=4 wt and 5 mut males and 6 wt and 14 het females). * p< 0.0001 Z-thickness of MIP projections on C and B is 15 m and these images correspond to areas outlined by white rectangles in A and B. Scale bars = 1 mm (A, B, E, F) and 50 m (C, D). Panel 3A reviews the numbering of individual cerebellar lobules. 
% fractions of (bGal+) PCs, in 32 week-old het females differ between cerebellar lobules affected and spared from degeneration of Purkinje cells.
Similar to lobule X, PCs that remain in lobule I-II uniformly express bGal (white arrowheads) in mut males. Small bGal+ non-PC nuclei largely correspond to the population of (Bergmann glia) astrocytes (supplementary material Fig. S1A ). Axons of these remaining PCs in lobule I-II develop spheroids (blue arrowhead in the inset) (A). bGal expression in PCs is mosaic (white arrowheads) in het females and varies among individual animals (B and C). The fraction of (bGal+) PCs is lower in lobule I-II compared to lobule X. bGal expression is mosaic also in other cell types within the PC layer (Bergmann glia astrocytes -supplementary material Fig. S1B ). (bGal+) PCs in het females also develop spheroids on their axons (blue arrowhead in the inset) (C).
The % fraction of bGal+ PCs in lobule I-II (n=17) is significantly lower than in lobule X (n=14) of het females (D). * p< 0.0001 Images shown for lobule I-II and X in A and B were collected from cerebella of a single mut male and het female, respectively. Lobule I-II PC densities and % fractions of (bGal+) PCs in A-C represent values for the particular animals shown. Open field (A-F) in 32-34 week-old animals (n=31 wt males, 30 mut males, 22 wt females and 33 het females). When compared to wt littermates, mut males demonstrated significantly higher locomotor activity (A: total track in cm) and exploration (B: number of rears). Anxiety-like behavior (C) was assessed as center zone exploration (center zone/total track length). No significant differences were identified between wt and het females (D-F).* indicates significant differences between wt and mut males (p< 0.05).
Z-thickness of MIP projections in
Balance beam test (G) in 20-22 week-old (n=25 wt males, 21 mut males, 22 wt females and 34 het females) and 32-34 week-old (n=25 wt males, 21 mut males, 17 wt females and 38 het females) animals. * indicates a significant main effect of age and # indicates a significant main effect of genotype.
Object placement test (H) in 20-22 week-old animals (n=15 wt males, 24 mut males, 17 wt females and 25 het females). Both wt males and wt females had intact visuospatial memory, indicated by a clear preference (exploration in seconds) for the re-located (New position) object. On the contrary, both mut males and het females demonstrated cognitive deficits as there was no preference for the object in the New position. * indicates significant difference between exploration of an object in a New and Old position (p< 0.05). For additional details see supplementary material Fig. S3 .
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TRANSLATIONAL IMPACT
Clinical issue
Christianson syndrome (CS) is an X-linked neurodevelopmental/neurological disorder associated in male patients with nonverbal status, epilepsy, ataxia, facial dysmorphology and intellectual disability (ID). Mutations in the SLC9A6 gene, which encodes a multi-pass transmembrane sodium (potassium)-hydrogen exchanger 6 protein believed located in early recycling endosomes, were linked to CS only recently. While large scale sequencing studies performed in families with X-linked intellectual disability suggested relatively high occurrence of SLC9A6 mutations, CS likely remains clinically underdiagnosed.
Similar to many other monogenic X-linked conditions, the phenotype as observed in X-hemizygous CS male patients remains in the spotlight of the clinical and experimental studies. Nonetheless, understanding the range and variability of the phenotypic presentation in females heterozygous for SLC9A6 mutations, who are subject to X-chromosome inactivation (XCI), remains critical both for efficient clinical identification of these individuals as well as genetic counselling in their families.
Mutant Slc9a6KO male mice are an established CS model presenting with impaired motor coordination and hyperactivity. At the molecular and cellular levels, neurons in these mice express attenuated TrkB signaling leading to neuritic arborization defects, selected neuronal populations accumulate glycolipids in late endosomes/lysosomes and lastly Purkinje cells (PC) succumb to patterned degeneration. Important for this study, the tissue expression of the mutant Slc9a6 allele can be traced in these mice by a -galactosidase reporter that allows testing of cellular/tissue/organismal effects of XCI on phenotypic penetrance in heterozygous Slc9a6KO female mice.
Results
The authors demonstrate that the mutant Slc9a6 allele is expressed mosaically in a broad range of cell types in the brain of heterozygous female mice. Correspondingly, lysosomal glycosphingolipid accumulation and PC degeneration are also distributed mosaically in these mice. Lastly, the authors show that heterozygous female mice present with visuospatial recognition and progressive motor coordination deficits reminiscent of abnormalities fully expressed in (mutant) Slc9a6KO male mice.
Implications and future directions
Slc9a6KO heterozygous female mice present with mitigated and variable behavioral phenotype and develop a mosaically distributed cellular (neuro)pathology corresponding to findings in X-hemizygous mutant males. As such, these (het) mice might serve as a valuable model for studies aiming at (neuro)pathogenesis of CS. Overall, conclusions drawn in this animal model study provide insights that should trigger further interest of clinicians and researchers to explore the range of CS phenotype in a likely underappreciated group of females heterozygous for SLC9A6 mutations.
